Antioxidants reduce reactive oxygen species but not embryotoxicity in the metabolic Danio rerio test (mDarT)

Casper Pype1, Evy Verbueken1, Moayad A Saad1

  • 1University of Antwerp, Applied Veterinary Morphology, Universiteitsplein 1, 2610 Wilrijk, Belgium.

Insights

Researchers attempted to reduce the embryotoxicity of metabolic activation systems (MAS) for drug testing in zebrafish embryos. Modifications failed to extend the limited exposure window, indicating MAS remains embryotoxic.

Area of Science:

  • Pharmacology and Toxicology
  • Developmental Biology
  • Drug Metabolism

Background:

  • Mammalian liver microsomes serve as a metabolic activation system (MAS) in zebrafish embryos (mDarT) to enhance drug bioactivation by cytochrome P450 (CYP).
  • The current MAS exhibits significant embryotoxicity, restricting the drug exposure window in zebrafish embryos.

Purpose of the Study:

  • To investigate methods for reducing the embryotoxic properties of MAS.
  • To extend the drug exposure window in the zebrafish embryo metabolic activation test (mDarT).

Main Methods:

  • Tested removal of microsomes from the incubation medium.
  • Assessed the impact of antioxidants on reactive oxygen species (ROS) levels.
  • Evaluated single dosing of NADPH and omission of toxic MAS components.

Main Results:

  • Removing microsomes did not mitigate MAS-induced embryotoxicity.
  • Antioxidants reduced ROS but did not resolve embryotoxicity.
  • Single NADPH dosing and MAS component modification failed to reduce toxicity.

Conclusions:

  • The study could not extend the mDarT exposure window by reducing ROS, altering NADPH dosing, or modifying the MAS preparation.
  • The inherent embryotoxicity of the MAS remains a significant limitation for zebrafish embryo drug testing.